This post can be read on Medium

Challenges and opportunities of COVID-19 for the cannabis industry →

April 30, 2020 in Cannabis

Featured

Why we invested in Maya Health?

August 12, 2021

Why we invested in Maya Health?

August 12, 2021

August 12, 2021

MDMA: Neurochemical mechanisms of action on the brain and its effectiveness in psychotherapy

August 12, 2021

MDMA: Neurochemical mechanisms of action on the brain and its effectiveness in psychotherapy

August 12, 2021

August 12, 2021

Debunking the common misconceptions behind cannabis

December 8, 2020

Debunking the common misconceptions behind cannabis

December 8, 2020

December 8, 2020

November 21, 2020

Clinical studies of Magic Mushrooms - Part 2

November 21, 2020

November 21, 2020

June 19, 2020

Neuroscience of Magic Mushrooms - Part I

June 19, 2020

June 19, 2020

April 30, 2020

Challenges and opportunities of COVID-19 for the cannabis industry

April 30, 2020

April 30, 2020

April 2, 2020

Why do we invest in companies maximising the therapeutic potential of cannabis and psychedelics?

April 2, 2020

April 2, 2020

photo_2020-02-16 19.58.26.jpeg

February 21, 2020

Key takeaways from Cannabis Europa Madrid

February 21, 2020

February 21, 2020

This post can be read on Medium

Why do we invest in companies maximising the therapeutic potential of cannabis and psychedelics? →

April 02, 2020 in psychedelics, investment, Cannabis

photo_2020-02-16 19.58.26.jpeg — This post can be read on Medium

Key takeaways from Cannabis Europa Madrid →

February 21, 2020 in Cannabis